Oncotarget · 2016 · 49 citations · 46 references
MedicineOncologyPathologyGastrointestinal OncologyMetastasisMolecular DiagnosticsCancer BiomarkersCancer Molecular DiagnosticsCancer Molecular PathologyEsophageal CancerGastric CancerTumor MarkersBiomarker DetectionBiomarkers Of Gastric CancerCathepsin ActivityCirculating Tumor Protein BiomarkersEnzyme-linked Immunosorbent Assay (Elisa)Immunohistochemical BiomarkersPrognostic BiomarkersSerum Tumor Markers
// Wan-Li Liu 1, 2, * , Dan Liu 1, 2, * , Kai Cheng 3 , Yi-Jun Liu 1, 2 , Shan Xing 1, 2 , Pei-dong Chi 1, 2 , Xiao-Hua Liu 1, 2 , Ning Xue 1, 2 , Yan-zhen Lai 1, 2 , Ling Guo 4 , Ge Zhang 3 1 State Key Laboratory of Oncology in Southern China, Sun Yat-sen University Cancer Center, Guangzhou, China 2 Department of Clinical Laboratory Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China 3 Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China 4 Department of Nasopharyngeal Carcinoma, Sun Yat-sen University of Cancer Center, Guangzhou, China * These authors have contributed equally to this work Correspondence to: Ge Zhang, email: zhangge@mail.sysu.edu.cn Keywords: Cat S, gastric cancer, diagnosis and prognostic biomarker, ELISA Received: December 09, 2015 Accepted: March 28, 2016 Published: April 5, 2016 ABSTRACT To evaluate whether serum Cathepsin S (Cat S) could serve as a biomarker for the diagnosis and prognosis of gastric cancer (GC), Enzyme-linked immuno sorbent assay (ELISA) was used to detect serum Cat S in 496 participants including healthy controls and patients with benign gastric diseases, gastric cancer, esophageal cancer, liver cancer, colorectal cancer, nasopharyngeal cancer and lung cancer. The levels of serum Cat S were significantly increased in cancer patients, especially in GC patients. The qRT-PCR, Western blotting, and immunohistochemical staining revealed the overexpression of Cat S in GC cell lines and tissues. The diagnostic value of serum Cat S for GC patients from controls resulted in an AUC of 0.803 with a sensitivity of 60.7% and a specificity of 90.0%. Moreover, the levels of serum Cat S were associated with GC tumor volume, lymphoid nodal status, metastasis status, and stages. Moreover, the patients with high levels of serum Cat S had a poorer overall survival. Univariate analysis revealed Cat S expression was a prognostic factor. The knockdown of Cat S significantly suppressed the migration and invasion of GC cells. This study suggested serum Cat S may be a potential biomarker for the diagnosis and prognosis of GC.
46
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
Vasilena Gocheva, Wei Zeng, Danxia Ke et al. · Genes & Development · 2006 · 579 citations · Full text